Table 3

Prevalence of RDT-positive malaria at ANC visits 2, 3 and 4

ISTPCDP value*
N (%)N (%)
ANC visit 2
 Total number of women17762391
 RDT done1663 (93.6)30 (1.3)<0.001
 RDT result
P. falciparum24 (1.4)1 (3.3)
P. vivax8 (0.5)4 (13.3)
 Mixed infection (Pf+Pv)
 Symptomatic malaria†
5 (0.3)
10 (27.0)
0
5 (100.0)
ANC visit 3
 Total number of women9301507
 RDT done856 (92.3)23 (1.5)<0.001
 RDT result
P. falciparum12 (1.4)1 (4.3)
P. vivax4 (0.5)7 (30.4)
 Mixed infection (Pf+Pv)
 Symptomatic malaria†
2 (0.2)
6 (33.3)
0
8 (100.0)
ANC visit 4
 Total number of women409651
 RDT done394 (96.3)0<0.001
 RDT result
P. falciparum3 (0.8)0
P. vivax1 (0.3)0
 Mixed infection (Pf+Pv)
 Symptomatic malaria†
3 (0.8)
4 (57.1)
0
0
  • *Pearson’s design-based test.

  • †RDT positive plus history of fever (<48 hours) or temperature>37.5°C.

  • ANC, antenatal clinic; IST, intermittent screening and treatment; P., Plasmodium; PCD, passive case detection; Pf, Plasmodium falciparum; Pv, Plasmodium vivax; RDT, rapid diagnostic test.